Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma

Clear cell renal cell carcinoma (ccRCC), one of the most common urologic cancer types, has a relatively good prognosis. However, clinical diagnoses are mostly done during the medium or late stages, when mortality and recurrence rates are quite high. Therefore, it is important to perform real-time in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Chuanchuan, Wang, Zichu, Xu, Chao, Huang, Xiao, Su, Junzhou, Chen, Bisheng, Wang, Mingshan, Qi, Zhihong, Bai, Peiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098777/
https://www.ncbi.nlm.nih.gov/pubmed/33968978
http://dx.doi.org/10.3389/fmolb.2021.609865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098777/
https://www.ncbi.nlm.nih.gov/pubmed/33968978
http://dx.doi.org/10.3389/fmolb.2021.609865

Ejemplares similares